Keyphrases
Vaccine Design
100%
MRNA Vaccine
100%
Immunoinformatics
100%
Influenza D Virus
100%
Vaccine Construct
57%
Epitope
28%
Vaccine Effectiveness
14%
Stronger Binding
14%
Secondary Structure
14%
MHC Class II
14%
Linker
14%
Binding Affinity
14%
3′-untranslated Region (3′-UTR)
14%
5′-untranslated Region (5′-UTR)
14%
Viral Genome
14%
Viral Outbreaks
14%
Toll-like
14%
Human Disease
14%
Human Health
14%
Antigenicity
14%
Viral Infection
14%
Virus Isolate
14%
Tertiary Structure
14%
Susceptibility to Infection
14%
B-cell Epitope
14%
Structure Analysis
14%
Immunological Response
14%
Bioinformatics Tools
14%
Physicochemical Properties
14%
Human Susceptibility
14%
Emerging Pathogen
14%
Vaccine Safety
14%
Animal Health
14%
Epitope Prediction
14%
Animal Vaccines
14%
Global Impact
14%
Molecular Docking
14%
Comprehensive Methodology
14%
Allergenicity
14%
CTL Cells
14%
Hemagglutinin-esterase
14%
Vaccine Prototype
14%
Immunology and Microbiology
Influenza
100%
Virus
100%
Epitope
57%
Vaccine Efficacy
28%
B Cell
14%
Infectious Agent
14%
Binding Affinity
14%
Viral Disease
14%
Antigenicity
14%
Adjuvant
14%
Animal Vaccines
14%
Molecular Docking
14%
Allergenicity
14%
Hemagglutinin Esterase
14%
Bioinformatics
14%
Tertiary Structure
14%
Toll-Like Receptor
14%
Pharmacology, Toxicology and Pharmaceutical Science
Epitope
100%
mRNA Vaccine
100%
Infection
25%
Infectious Agent
25%
Virus Infection
25%
Adjuvant
25%
Esterase
25%
Toll Like Receptor
25%
Vaccine Efficacy
25%
Molecular Docking Simulations
25%
Hemagglutinin
25%
Diseases
25%
Biochemistry, Genetics and Molecular Biology
Messenger RNA
100%
B Cell
25%
Infectious Agent
25%
Binding Affinity
25%
Tertiary Structure
25%
Structure Analysis
25%
Antigenicity
25%
Toll-Like Receptor
25%
Docking (Molecular)
25%
Hemagglutinin Esterase
25%
Allergenicity
25%
Bioinformatics
25%